Westmount Partners’s AbbVie ABBV Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$1.44M Sell
5,727
-6,457
-53% -$1.39M 0.32% 70
2026
Q1
$2.65M Buy
12,184
+7,178
+143% +$1.59M 0.65% 33
2025
Q4
$1.14M Sell
5,006
-21
-0.4% -$4.78K 0.29% 70
2025
Q3
$1.23M Buy
5,027
+24
+0.5% +$4.89K 0.32% 68
2025
Q2
$929K Sell
5,003
-116
-2% -$21.6K 0.26% 78
2025
Q1
$1.07M Sell
5,119
-26
-0.5% -$5.05K 0.33% 67
2024
Q4
$914K Sell
5,145
-43
-0.8% -$7.91K 0.28% 71
2024
Q3
$1.02M Buy
5,188
+16
+0.3% +$2.99K 0.31% 68
2024
Q2
$881K Buy
5,172
+152
+3% +$25.2K 0.29% 71
2024
Q1
$914K Buy
5,020
+2
+0% +$345 0.33% 66
2023
Q4
$778K Sell
5,018
-153
-3% -$22.3K 0.32% 71
2023
Q3
$771K Buy
5,171
+458
+10% +$67.2K 0.34% 70
2023
Q2
$635K Sell
4,713
-25
-0.5% -$3.67K 0.28% 79
2023
Q1
$755K Sell
4,738
-25
-0.5% -$3.82K 0.35% 65
2022
Q4
$770K Buy
+4,763
New +$730K 0.4% 59

Other funds holding ABBV